<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT201204055168N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2012-07-03</date_registration>
      <primary_sponsor>Research of Nursing and Midwifery faculty, Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>Assesment of hypothermia complication  in two methods , head cooling and total body cooling in neonatal with birth asphyxia</public_title>
      <acronym></acronym>
      <scientific_title>Assesment of hypothermia compllication  , in Two methods , head cooling and total body cooling in neonatal with birth asphyxia</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2011-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/5517</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Supportive.</study_design>
      <phase>N/A</phase>
      <hc_freetext>neonates with moderate to severe birth asphyxia.</hc_freetext>
      <i_freetext>Intervention 1: Thirty neonatal with moderate and severe asphyxia cooled  with head cooling method to achieve the target temperature (rectal 34-33) for 1 hour,and held for 72 hours at this temperature, The neonatal are heated gradually during the 8-12 time to reach the normal temperature (36.5). Intervention 2: In the second group thirty neonatal with moderate and severe asphyxia cooled with total bady cooling method,using  Turn off Varmr and cold water bag (15-10)° C,to achieve the target temperature (rectal 32.5-33.5) for 1 hour,and held for 72 hours at this temperature, Then neonatal are heated gradually during the 8-12 time to reach the normal temperature (36.5).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Maliheh Assadollahi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Pediatric Department of nursing and midwifery faculty</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>51745-347</zip>
        <telephone>+98 41 1479 9713</telephone>
        <email>assadollahim@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Abdollah Janatdost</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nursing and Midwifery faculty, South Shariati Street, Tabriz.</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>51745-347</zip>
        <telephone>+98 41147997</telephone>
        <email>0098assadollahim@tbzmed.ac.ir</email>
        <affiliation>Tabriz university of medical &amp; health</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria &#13;
1. Infants with gestational age 35 weeks or more,&#13;
2. Six – hour infant or less than that&#13;
3. Infants weight more than 1800g&#13;
4. Apgar score 6 or less within 10 minutes from birth&#13;
5. Cord of pH 7 or less alkali deficiency 12 or less&#13;
6. Hypoxia ischemic encephalopathy moderate or severs&#13;
7. Infants with normal respiratory condition and infants under ventilation&#13;
 Exclusion criteria: &#13;
1. Infants with bradycardia less than 70,&#13;
 2. Infants with hypotension any response to medication,&#13;
 3. Infants with severe pulmonaryhemorage,&#13;
4. Coagulation disorders,&#13;
 5. Resistance hypoxia,</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G90-G99</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Diseases of the nervous system</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Thirty neonatal with moderate and severe asphyxia cooled  with head cooling method to achieve the target temperature (rectal 34-33) for 1 hour,and held for 72 hours at this temperature, The neonatal are heated gradually during the 8-12 time to reach the normal temperature (36.5).</i_keyword>
      <i_keyword>In the second group thirty neonatal with moderate and severe asphyxia cooled with total bady cooling method,using  Turn off Varmr and cold water bag (15-10)° C,to achieve the target temperature (rectal 32.5-33.5) for 1 hour,and held for 72 hours at this temperature, Then neonatal are heated gradually during the 8-12 time to reach the normal temperature (36.5).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Apnea. Timepoint: Every 4 hours for 84 hours. Method of measurement: Color Cyanosis, bradycardia, and arterial oxygen saturation less than 70% when using pulse oximetry or monitor device.</prim_outcome>
      <prim_outcome>Bradycardia. Timepoint: Every 4 hours for 84 hours. Method of measurement: Using the monitor device.</prim_outcome>
      <prim_outcome>Convulsion. Timepoint: Every 4 hours for 84 hours. Method of measurement: Using clinical symptoms and the presence of waves with short wave length and high frequency in the EEG.</prim_outcome>
      <prim_outcome>Hypotension. Timepoint: Every 4 hours for 84 hours. Method of measurement: Using the Monitor.</prim_outcome>
      <prim_outcome>Thrombocytopenia. Timepoint: Every 24 hours for 84 hours. Method of measurement: CBC test.</prim_outcome>
      <prim_outcome>Necrotic skin damage. Timepoint: Every 4 hours for 84 hours. Method of measurement: Clinical observation of ecchymosis, bruises, wounds  deep and necrotic skin.</prim_outcome>
      <prim_outcome>Pulmonary hemorrhage. Timepoint: Every 4 hours for 84 hours. Method of measurement: Using clinical signs and symptoms of pulmonary hemorrhage on chest radiograph confirmed by physician.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Research of Nursing and Midwifery faculty, Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2012-03-12</approval_date>
        <contact_name>Tabriz University of Medical Sciences</contact_name>
        <contact_address>- Tabriz University of Medical Sciences - Research Tabriz  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
